Pro-inflammatory Pyroptotic Cell Death in Aortic Degeneration
主动脉变性中的促炎焦亡细胞死亡
基本信息
- 批准号:10237565
- 负责人:
- 金额:$ 60.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AminesAortaAortic DiseasesAortic InjuryApoptosisAtherosclerosisBiomechanicsCardiovascular DiseasesCause of DeathCell DeathCell membraneCellsClinicalCytosolDNADNA DamageDNA-dependent protein kinaseDataDevelopmentDiabetic AngiopathiesDilatation - actionDiseaseDisease ProgressionDissectionEmergency SituationEventExtracellular MatrixExtravasationFailureGenerationsGenetic DiseasesGoalsHeart failureHypertensionIn VitroInflammationInflammatoryKnockout MiceLearningLifeLinkMarfan SyndromeMediatingMissionMitochondriaModelingMolecularMusNational Heart, Lung, and Blood InstituteNecrosisOperative Surgical ProceduresOxidative StressPathogenesisPathway interactionsPatientsPharmaceutical PreparationsPharmacologyPhosphotransferasesPreventionPublic HealthResearchRoleRuptureSeriesSignal PathwaySignal TransductionSmooth Muscle MyocytesStimulator of Interferon GenesSting InjuryStructureTBK1 geneTestingThoracic Aortic AneurysmTissuesUnited StatesVDAC1 geneVascular DiseasesWorkascending aortabaseexperimental studyimprovedin vivoinhibitor/antagonistknock-downmouse modelnovelpreventsensortherapeutic targettreatment strategy
项目摘要
Project Summary
Ascending thoracic aortic aneurysms and dissections (ATAAD), either associated with genetic conditions or
spontaneous as sporadic ATAAD, are extremely lethal diseases that often present as surgical emergencies.
Unfortunately, no clinically proven medication is available to prevent sporadic ATAAD progression. There is a
critical need to develop effective pharmacological strategies to treat ATAAD. The hallmark of sporadic ATAAD
is progressive aortic smooth muscle cell (SMC) depletion and extracellular matrix (ECM) destruction leading to
aortic dilatation, dissection, and ultimately rupture. Our long-term goal is to improve our understanding of the
molecular pathogenesis of sporadic ATAAD in hope of developing new pharmacological strategies to prevent
disease progression. Our preliminary studies suggest that damaged DNA in SMCs activates a pore-forming
protein, gasdermin D (GSDMD), that drives SMC pyroptosis, an inflammatory form of programmed cell death
that may represent a common pathway to aortic SMC loss. Therefore, the objectives of this application are to
determine the role and mechanisms of GSDMD-mediated SMC pyroptosis in ATAAD development and to ex-
amine the extent to which cytosolic DNA sensing and pyroptosis represent therapeutic targets against ATAAD.
Our central hypothesis is that sensor pathways triggered by damaged DNA activate GSDMD-mediated SMC
pyroptosis, leading to aortic degeneration, dissection, and rupture. In Aim 1, we will determine the role of
GSDMD-mediated SMC pyroptosis in ATAAD formation. We will test the hypothesis that GSDMD-mediated
SMC pyroptosis is critically involved in aortic degeneration, biomechanical failure, and ATAAD development by
examining these aspects in Gsdmd-/-mice and inducible SMC-specific Gsdmd knockout mice in our established
sporadic ATAAD model. In Aim 2, we will investigate the mechanisms underlying the activation of GSDMD-
mediated SMC pyroptosis. In a series of in vitro and in vivo experiments, we will test the hypothesis that cyto-
solic DNA-triggered cGAS-STING sensor signaling, through TBK1/IKK2/DNA-PK kinases, directly phosphory-
lates GSDMD and promotes its activation and pore formation in plasma membranes, leading to mitochondrial
damage and ultimately pyroptotic SMC death. In Aim 3, we will determine the extent to which suppressing cy-
tosolic DNA sensing and pyroptotic cell death will prevent ATAAD development and progression. We will test
the hypothesis that simultaneously blocking the cGAS-STING pathway and pyroptosis will prevent aortic de-
struction and disease progression in our sporadic ATAAD model. We expect that this work will determine how
damaged DNA induces pyroptosis and thereby compromises the structure and function of the ascending aortic
wall. The positive impact of this work will be an improved understanding of the molecular mechanisms that
cause SMC pyroptosis in the development of aortic degeneration, providing an exciting new direction for treat-
ment strategies for preventing ATAAD formation and its fatal sequelae. The novel mechanisms regarding DNA
damage-induced pyroptotic cell death will also have broad implications in many other cardiovascular diseases.
1
项目摘要
升主动脉瘤和夹层(ATAAD),与遗传疾病或
自发性作为散发性ATAAD,是一种极其致命的疾病,通常表现为外科紧急情况。
不幸的是,没有临床证明的药物可以防止零星的ATAAD进展。有一个
迫切需要制定有效的药理学策略来治疗ATAAD。散发性ATAAD的特点
是进行性的主动脉平滑肌细胞(SMC)耗竭和细胞外基质(ECM)破坏导致
主动脉扩张,夹层,最终破裂。我们的长期目标是提高我们对
散发性ATAAD的分子发病机制希望开发新的药理学策略来预防
疾病的发展。我们的初步研究表明,SMC中受损的DNA激活了一种成孔作用
Gasdermin D(GSDMD)蛋白,可导致SMC下垂,这是一种炎性形式的程序性细胞死亡
这可能是导致主动脉SMC丧失的常见途径。因此,此应用程序的目标是
探讨GSDMD介导的SMC下垂在ATAAD发病中的作用及机制。
胺胞浆DNA传感和上睑下垂代表ATAAD治疗靶点的程度。
我们的中心假设是,DNA损伤触发的传感器通路激活GSDMD介导的SMC
上睑下垂,导致主动脉变性、夹层和破裂。在目标1中,我们将确定
GSDMD介导的ATAAD形成的SMC下垂。我们将检验GSDMD介导的假设
SMC下垂与主动脉退行性变、生物力学衰竭和ATAAD的发生密切相关。
在Gsdmd-/-小鼠和我们建立的可诱导的SMC特异性Gsdmd基因敲除小鼠中检测这些方面
零星的ATAAD模型。在目标2中,我们将研究GSDMD激活的机制-
介导的SMC上睑下垂。在一系列体外和体内实验中,我们将检验细胞-
Solic DNA触发的cGAS-STING传感器信号,通过TBK1/IKK2/DNA-PK激酶,直接磷酸化-
延缓GSDMD并促进其在质膜上的激活和孔形成,导致线粒体
损害并最终导致SMC死亡。在目标3中,我们将确定抑制细胞周期的程度-
胞质DNA传感和嗜焦性细胞死亡将阻止ATAAD的发生和进展。我们将测试
假设同时阻断cGAS刺痛通路和上睑下垂可以预防主动脉脱垂。
我们的散发性ATAAD模型中的结构和疾病进展。我们希望这项工作将决定如何
DNA损伤导致上睑下垂,从而损害升主动脉的结构和功能
墙。这项工作的积极影响将是更好地理解
在主动脉退行性变的发展中引起SMC下垂,为治疗提供了一个令人兴奋的新方向--
预防ATAAD形成及其致命后遗症的治疗策略。关于DNA的新机制
损伤诱导的嗜酸性细胞死亡在许多其他心血管疾病中也有广泛的意义。
1
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT A LEMAIRE其他文献
SCOTT A LEMAIRE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT A LEMAIRE', 18)}}的其他基金
Pro-inflammatory Pyroptotic Cell Death in Aortic Degeneration
主动脉变性中的促炎焦亡细胞死亡
- 批准号:
10643934 - 财政年份:2021
- 资助金额:
$ 60.11万 - 项目类别:
Pro-inflammatory Pyroptotic Cell Death in Aortic Degeneration
主动脉变性中的促炎焦亡细胞死亡
- 批准号:
10435503 - 财政年份:2021
- 资助金额:
$ 60.11万 - 项目类别:
Mitochondrial Damage-Induced Necroptotic Cell Death in SporadicAscending Thoracic Aortic Aneurysms and Dissections
散发性升主动脉瘤和夹层中线粒体损伤诱导的坏死性细胞死亡
- 批准号:
9980977 - 财政年份:2018
- 资助金额:
$ 60.11万 - 项目类别:
Mitochondrial Damage-Induced Necroptotic Cell Death in SporadicAscending Thoracic Aortic Aneurysms and Dissections
散发性升主动脉瘤和夹层中线粒体损伤诱导的坏死性细胞死亡
- 批准号:
9765053 - 财政年份:2018
- 资助金额:
$ 60.11万 - 项目类别:
Mitochondrial Damage-Induced Necroptotic Cell Death in SporadicAscending Thoracic Aortic Aneurysms and Dissections
散发性升主动脉瘤和夹层中线粒体损伤诱导的坏死性细胞死亡
- 批准号:
10239058 - 财政年份:2018
- 资助金额:
$ 60.11万 - 项目类别:
Targeting the Inflammasome to Prevent Thoracic Aortic Aneurysms and Dissections
针对炎症小体预防胸主动脉瘤和夹层
- 批准号:
9247885 - 财政年份:2016
- 资助金额:
$ 60.11万 - 项目类别:
Targeting ER Stress To Treat Aortic Aneurysms and Dissections
针对内质网应激治疗主动脉瘤和夹层
- 批准号:
9338945 - 财政年份:2016
- 资助金额:
$ 60.11万 - 项目类别:
Targeting ER stress to Treat Aortic Aneurysms and Dissections
针对内质网应激治疗主动脉瘤和夹层
- 批准号:
9081997 - 财政年份:2016
- 资助金额:
$ 60.11万 - 项目类别:
Targeting the Inflammasome to Prevent Thoracic Aortic Aneurysms and Dissections
针对炎症小体预防胸主动脉瘤和夹层
- 批准号:
9130437 - 财政年份:2015
- 资助金额:
$ 60.11万 - 项目类别:
NATIONAL REGISTRY OF GENETICALLY TRIGGERED THORACIC AORTIC ANEURYSMS
国家基因触发胸主动脉瘤登记处
- 批准号:
8356739 - 财政年份:2010
- 资助金额:
$ 60.11万 - 项目类别:
相似海外基金
Deep learning to enable the genetic analysis of aorta
深度学习可实现主动脉的遗传分析
- 批准号:
10807379 - 财政年份:2023
- 资助金额:
$ 60.11万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 60.11万 - 项目类别:
Development of new preventive method for postoperative paraplegia of thoracoabdominal aorta using exosomes
利用外泌体开发胸腹主动脉术后截瘫的新预防方法
- 批准号:
22K08940 - 财政年份:2022
- 资助金额:
$ 60.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Hemodynamic Mechanisms of Heart-Aorta-Brain Coupling with An Integrated Preventive Medicine Education Program for Socioeconomically Disadvantaged Groups
职业:心-主动脉-脑耦合的血流动力学机制以及针对社会经济弱势群体的综合预防医学教育计划
- 批准号:
2145890 - 财政年份:2022
- 资助金额:
$ 60.11万 - 项目类别:
Continuing Grant
Dissecting the role of hemodynamics in ascending aorta aneurysm development in bicuspid aortic valve disease
剖析血流动力学在二叶式主动脉瓣疾病升主动脉瘤发展中的作用
- 批准号:
500274 - 财政年份:2022
- 资助金额:
$ 60.11万 - 项目类别:
Studentship Programs
Smooth muscle cell diversity and thoracic aorta vulnerability
平滑肌细胞多样性和胸主动脉脆弱性
- 批准号:
453372 - 财政年份:2021
- 资助金额:
$ 60.11万 - 项目类别:
Operating Grants
Deep learning to enable the genetic analysis of aorta
深度学习可实现主动脉的遗传分析
- 批准号:
10613402 - 财政年份:2021
- 资助金额:
$ 60.11万 - 项目类别:
Development of bifurcated curved bio-tube for the aorta with in-body tissue architecture
开发具有体内组织结构的主动脉分叉弯曲生物管
- 批准号:
21H03819 - 财政年份:2021
- 资助金额:
$ 60.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)